According to the latest report by IMARC Group “Immunoglobulin Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028“, The global immunoglobulin market size reached US$ 14.7 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 21.1 Billion by 2028, exhibiting a growth rate (CAGR) of 6% during 2023-2028.
Immunoglobulins, also known as antibodies, refer to a type of glycoprotein molecule created by plasma or white blood cells (WBC). They are found in the serum and cells of the immune system and function as antibodies by explicitly recognizing and binding antigens such as viruses or bacteria and aiding in their destruction. They help medical professionals diagnose autoimmune diseases, allergies, and immunodeficiencies, such as lupus, celiac disease, and juvenile idiopathic arthritis, by measuring the immunoglobulin level in a blood sample. They are commonly administered through intravenous and subcutaneous routes of delivery. As a result, immunoglobulins are widely used to treat immunological and neurological conditions, including chronic inflammatory demyelinating polyneuropathy (CIDP), hypogammaglobulinemia, and myasthenia gravis.
Request for a free sample copy of this report: https://www.imarcgroup.com/immunoglobulin-market/requestsample
Market Trends:
The market is primarily driven by the growing prevalence of immunodeficiency disorders such as hepatitis, leukemia, and multiple myeloma across the globe. In addition, rapid urbanization, hectic working schedules, sedentary lifestyles, and increasing consumption of fast foods are contributing to the rising burden of several medical conditions, including Waldenstrom macroglobulinemia and autoimmune disorders. Moreover, the recent onset of the coronavirus (COVID-19) pandemic resulted in the escalating demand for hyperimmune globulin as an effective medicine to manage the disease among hospitalized patients, which represents another major growth-inducing factor. Besides this, the rising awareness regarding early diagnosis and personalized medicines and the widespread adoption of immunoglobulins to help the body fight infectious diseases are accelerating market growth. Furthermore, several leading pharmaceutical companies are introducing new and advanced immunoglobulins with improved efficacy to treat neurological disorders and are extensively investing in research and development (R&D) activities, which in turn is creating a positive market outlook.
Breakup by Product:
Breakup by Application:
- Hypogammaglobulinemia
- Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- Immunodeficiency Disease
- Myasthenia Gravis
- Others
Breakup by Mode of Delivery:
- Intravenous Mode of Delivery
- Subcutaneous Mode of Delivery
Market Breakup by Region:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
Competitive Landscape with Key Player:
- ADMA Biologics Inc.
- Baxter international Inc.
- Biotest AG
- CSL Limited
- Grifols S.A
- Kedrion S.p.A
- LFB SA
- Octapharma AG
- Sanquin Plasma Products B.V.
- Takeda Pharmaceutical Company Limited.
Ask Analyst for Customization and Browse full report with TOC & List of Figure: https://www.imarcgroup.com/immunoglobulin-market
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
Contact US
IMARC Group
Email: sales@imarcgroup.com
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Address: 134 N 4th St. Brooklyn, NY 11249, USA
Follow us on Twitter: @imarcglobal
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Italiano
Russian
Romaian